Biocept Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BIOC Nasdaq 2834 http://www.biocept.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biocept Inc

Biocept Announces Commercial Launch of Target Selector™ NGS Breast Panel, the Company's Second Multi-Gene Tumor-Specific Panel - Jun 18th, 2019 6:05 am
Biocept to Present at the 9th Annual LD Micro Invitational Conference on June 4 - Jun 3rd, 2019 6:05 am
Biocept Awarded Patent in China for its Circulating Tumor Cell Platform Expanding Intellectual Property Estate to 33 Issued Patents Globally - May 28th, 2019 6:05 am
Biocept's stock soars on heavy volume after commercial launch of liquid biopsy test for lung cancer - May 20th, 2019 1:07 pm
Biocept Announces Clinical Validation and Commercial Launch of its Target Selector™ Multi-Gene Liquid Biopsy Panel for Lung Cancer - May 20th, 2019 6:05 am
Biocept Reports First Quarter 2019 Financial Results - May 8th, 2019 2:05 pm
Biocept to Release First Quarter 2019 Financial Results and Host Investor Conference Call on May 8, 2019 - May 1st, 2019 6:05 am
Biocept Reports 2018 Fourth Quarter and Full Year Financial Results - Mar 28th, 2019 2:05 pm
Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment - Mar 26th, 2019 6:05 am
Biocept to Release 2018 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2019 - Mar 21st, 2019 6:05 am
Biocept Awarded Patent in Japan for the Capture of Rare Cells Including CTCs from Any Biological Sample of Interest with A Microchannel Device - Mar 18th, 2019 6:05 am
Biocept, Potential Near-Term Catalysts for Biocept - Mar 18th, 2019 6:00 am
Biocept Announces Pricing of $8.2 Million Registered Direct Offering - Mar 15th, 2019 7:00 am
Biocept Expands its Pathology Partnership Offering for Liquid Biopsy with the Addition of Several Key Services - Mar 13th, 2019 6:05 am
Biocept's Liquid Biopsy Test for ESR1 Biomarker Detection to be Featured in Poster Presentation at the 2019 AACR Annual Meeting - Mar 4th, 2019 6:05 am
Four Healthcare Stocks Getting A Boost On Wednesday - Feb 27th, 2019 8:00 am
Biocept and Providence Saint John's Health Center Collaborate to Evaluate Cerebrospinal Fluid for Use with Liquid Biopsy Testing in Metastatic Cancer - Feb 27th, 2019 6:05 am
Biocept Issues Letter to Stockholders - Feb 20th, 2019 6:05 am
What Makes Biocept (BIOC) a New Buy Stock - Feb 13th, 2019 7:34 am
Biocept Announces Pricing of $7.5 Million Underwritten Public Offering - Feb 8th, 2019 6:45 am